VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by tigop213on Dec 29, 2020 2:15pm

330 Views

Post# 32192663

Uniform Treatment Strategy

Believe you could and you're halfway there.I've always been interested in knowing more and got to bump into this today.might want to read thiis one too.

Better, the remission rates of the Actinium Pharmaceuticals study appear to be far better, as compared to other therapies that have been approved for treatment.check dc on my profile

As reported by Targeted Oncology, as compared to Actinium Pharmaceuticals’ overall response rate approx. 86%, others aren’t even in the same ballpark

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec